Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Tue, 08/15/23 - 10:03 am
Sandoz
generics
biosimilars
Eylea
Novartis
wet age-related macular degeneration
Pfizer Lawsuit Seeks to Block Generic Copy of Heart Disease Blockbuster
BioSpace
Mon, 08/14/23 - 06:47 pm
Pfizer
generics
legal
Vyndamax
heart disease
patents
tafamidis
Dexcel Pharma
Eliquis: the cardio drug that cannot be beat
EP Vantage
Fri, 08/4/23 - 10:14 am
Bristol Myers Squibb
Eliquis
generics
In win for generics industry, Viatris wards off $50M payment in tax battle with IRS
Fierce Pharma
Mon, 07/31/23 - 10:06 pm
Viatris
IRS
taxes
patents
generics
Gilead, Teva prevail in high-stakes trial over HIV drug pay-for-delay claims
Fierce Pharma
Wed, 07/5/23 - 07:17 pm
Gilead Sciences
Teva Pharmaceutical
HIV
pay-for-delay
generics
legal
Sanofi blocks Sandoz's Jevtana generic in patent win
Fierce Pharma
Fri, 06/30/23 - 10:16 am
Sanofi
Jevtana
generics
Sandoz
prostate cancer
legal
Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Medical Marketing and Media
Wed, 06/21/23 - 11:51 am
generics
cancer
drug shortages
ADHD
antibiotics
Cisplatin
carboplatin
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Fierce Pharma
Thu, 06/8/23 - 09:29 pm
Novartis
Sandoz
generics
biosimilars
US Military Is So Worried About Drug Safety It Wants to Test Widely Used Medicines
Bloomberg
Thu, 06/8/23 - 09:53 am
Valisure
generics
Department of Defense
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
Fierce Pharma
Thu, 05/18/23 - 11:16 am
JNJ
schizophrenia
generics
Trinza
Viatris
Drug Shortages Near an All-Time High, Leading to Rationing
NY Times, NY
Wed, 05/17/23 - 11:10 am
drug shortages
cancer
generics
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Tue, 05/16/23 - 12:12 pm
Novartis
Sandoz
biosimilars
generics
women executives
SCOTUS Kills Hope for Eligibility Certainty and Nixes Teva’s ‘Skinny Label’ Appeal
IP Watchdog
Mon, 05/15/23 - 06:37 pm
Teva Pharmaceutical
Supreme Court
generics
legal
skinny labels
Senate health committee seeks to rein in drug prices with four new bills
BioSpace
Fri, 05/12/23 - 11:47 am
Senate
drug pricing
generics
PBMs
legislation
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Fierce Pharma
Thu, 05/4/23 - 09:00 pm
Novartis
Sandoz
generics
Adalvo
12,000 diseases lack treatments. One doctor thinks generics could yield cures
Stat
Thu, 05/4/23 - 08:57 pm
orphan diseases
generics
artificial intelligence
Sanders, Cassidy reach deal to increase access to generic prescription drugs, reform PBMs
Fierce Healthcare
Tue, 04/25/23 - 10:13 pm
legislation
PBMs
generics
Senate
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Fierce Pharma
Thu, 04/20/23 - 11:47 am
Amgen
Otezla
immunology
generics
Sandoz
Zydus
patents
Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys
Fierce Pharma
Wed, 04/12/23 - 10:07 pm
Takeda
pay-for-delay
generics
gout
Colcrys
Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design
Drug Channels
Tue, 04/4/23 - 10:16 am
drug pricing
generics
PBMs
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »